NEW YORK (TheStreet
) -- CHANGE IN RATINGS
BSX was upgraded at JMP Securities to outperform from market perform. $9 price target. Company is on the cusp of a multiyear growth period, JMP said.
BVN was downgraded to hold at TheStreet Ratings.
CRR was upgraded to buy at TheStreet Ratings.
CNK was downgraded at JP Morgan from overweight to neutral. $30 price target. Valuation call, as the stock is up 53% year to date, JP Morgan said.
DECK was upgraded at Sterne Agee from neutral to buy. $65 price target. Business can turn by the second half of 2013, Sterne Agee said.
DELL was upgraded at Goldman Sachs from sell to buy. $13 price target. Solid cash position should help place a floor on the stock, Goldman said.
EIX was downgraded at Bernstein Research to market perform. Valuation call, based on a $50 price target. Company faces potential growth headwinds, Bernstein said.
EV was upgraded at Goldman Sachs to neutral from sell. $29.50 price target. Better flow outlook, but valuation still stretched, Goldman said.
FNSR was upgraded at Needham from hold to buy. $18 price target. Service provider spending should increase over the coming quarters for the company's new products, Needham said.
IGT was upgraded at Deutsche Bank from hold to buy. $19 price target. Worst operating trends are likely behind the company, Deutsche Bank.
Janus Capital Group
JNS was downgraded at Goldman Sachs to sell from neutral. $7 price target. Tougher flow outlook not priced in, Goldman said.
LULU was initiated with a buy rating at Canaccord Genuity. $91 price target. Company is evolving beyond its athletic roots, Canaccord said.
OXY was downgraded at Deutsche Bank from buy to hold. $80 price target.
PRE was downgraded at UBS to neutral from buy. $84 price target. Valuation call, UBS said.
RATE was downgraded at Canaccord Genuity to hold. $14 price target. Company faces tough comps, Canaccord said.
RGC was downgraded at JP Morgan from overweight to neutral. Valuation call, as the stock is up 39% year to date, JP Morgan said. $17 price target.
Research In Motion
RIMM was downgraded at Canaccord to sell. Valuation call, based on a $10 price target. Core fundamentals remain soft, Canaccord said.
TEVA was downgraded at UBS to neutral from buy. $41 price target. Company's transition will take time, UBS said.
VZ was upgraded at Nomura from neutral to buy. $50 price target. Company has superior execution and can continue to grow, Nomura said.
WSM was upgraded at Morgan Stanley from equal-weight to overweight. $54 price target. Business is improving and the company can post double-digit annual growth over the next few years, Morgan Stanley said.
WWD was downgraded at Drexel Hamilton to hold. Valuation call, Drexel said.
STOCK COMMENTS / EPS CHANGES
ALB target raised at Jefferies tO $77, Jefferies said. Improvements in end markets. Buy rating.
AME numbers raised at Jefferies.
Shares of AME now seen reaching $44, Jefferies said. Estimates also raised 2013 productivity goal large. Buy rating.
FDX numbers lowered at Citigroup.
Shares of FDX now seen reaching $103, Citigroup said. Estimates also lowered as express headwinds persist. Buy rating.
HUN estimates lowered at UBS through 2013, UBS said. Softer 4Q expected by company. Buy rating and $16 price target.
TEVA estimates, target reduced at Credit Suisse.
Shares of TEVA now seen reaching $50, according to Credit Suisse. Estimates also cut, given the company's new guidance. Outperform rating.
THOR added to Conviction Buy List at Goldman. Estimates also boosted, as the company can gain market share. $48 price target.
TOL target raised at Citigroup to $34 to reflect peer multiple expansion, Citigroup said. Neutral rating.
>To submit a news tip, email: email@example.com
READERS ALSO LIKE:
and become a fan on Facebook.
Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE. Sign up today to get e-mail alerts before every trade.